Prof. Farhad Hafezi, MD, PhD, FARVO, has been appointed to the Editorial Board of EuroTimes, the official publication of the European Society of Cataract and Refractive Surgeons (ESCRS). This role further solidifies his contributions to ophthalmic research, education, and innovation.
New CXL research challenges the role of oxygen in corneal cross-linking. Can oxygen-independent CXL improve keratoconus treatment? Find out how this breakthrough could change clinical practice.
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
Dr. Emilio A. Torres-Netto has been recognized as a TouchOphthalmology Future Leader 2025 for his groundbreaking work in corneal and refractive surgery.
Intracorneal ring segments (ICRS) can offer significant corneal flattening and vision rehabilitation effects in suitable corneas. This article explores the differences between different ring segments, and the latest advances in ICRS like Femto-CAIRS.
Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).
Dual chromophore PACK-CXL treatment using riboflavin/UV-A and rose bengal/green light may offer an effective solution for refractory Acanthamoeba keratitis.
“I actually heard about the ELZA Institute from my cigar dealer,” they laughed. “And Syfovre? I just Googled it and saw it was from America and very expensive.”
Expert review in Eyenet of corneal cross-linking as an adjunctive treatment for infectious keratitis and corneal melting.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
